VIR
#2130
Vir Biotechnology, Inc. - Common Stock
9.7 2 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.41%
Monthly Change
+11.34%
6 month change
+42.73%
Year Change
+62.54%
Previous Close
9.9 6
Open
9.7 2
Low
9.7 2
High
9.7 2
Volume
117
Financials
- Market Capitalization 1.64 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.91
Price to sales ratio
12.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2124 |  IMCR Immunocore Holdings plc - American Depositary Shares | 32.49 USD | +1.69% | +1.15% | +12.19% | -2.96% | 1.65 B USD | ||
| 2127 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.36 USD | +4.43% | +7.80% | +26.69% | +139.10% | 1.64 B USD | ||
| 2131 |  INVA Innoviva, Inc. - Common Stock | 22.21 USD | -0.13% | +0.45% | -2.24% | +24.64% | 1.64 B USD | ||
| 2146 |  ABSI Absci Corporation - Common Stock | 10.21 USD | -3.68% | -14.06% | +38.72% | +283.83% | 1.59 B USD |
Frequently asked questions about Vir Biotechnology, Inc. - Common Stock
What is the Vir Biotechnology, Inc. - Common Stock stock price today?
The current price of Vir Biotechnology, Inc. - Common Stock (VIR) is 9.72. Over the past 24 hours, the stock has changed by -2.41%. Follow the VIR chart for real-time price dynamics.
What is the stock ticker of Vir Biotechnology, Inc. - Common Stock?
Vir Biotechnology, Inc. - Common Stock trades under the ticker VIR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vir Biotechnology, Inc. - Common Stock stock going up?
VIR has changed by -4.33% over the last week, +11.34% over the last month, and +62.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Vir Biotechnology, Inc. - Common Stock release financial reports?
Yes. You can track Vir Biotechnology, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Vir Biotechnology, Inc. - Common Stock net income for the last quarter?
Vir Biotechnology, Inc. - Common Stock reported net income of -125.69 M for the last quarter. The previous quarter showed -42.92 M, which means net income changed by -192.84%.
How many employees does Vir Biotechnology, Inc. - Common Stock have?
As of the latest available data, Vir Biotechnology, Inc. - Common Stock has 367 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vir Biotechnology, Inc. - Common Stock EBITDA?
Vir Biotechnology, Inc. - Common Stock EBITDA is -129.48 M, and its EBITDA margin is 446.48 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vir Biotechnology, Inc. - Common Stock stock?
You can buy Vir Biotechnology, Inc. - Common Stock (VIR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vir Biotechnology, Inc. - Common Stock stock?
Investing in Vir Biotechnology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VIR chart and related analysis on metatrader.com as part of your research.